China launches major trial for rare cancer breakthroughs
NCT ID NCT07307053
Summary
This study aims to test the safety and effectiveness of several new cancer treatments and technologies for people with advanced rare solid tumors. Researchers will use detailed molecular testing to match 600 participants with specific treatment options, including drugs, cell therapies, and vaccines. The trial is for patients who have already tried standard treatments without success or have no standard options available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.